Lanean...
Herpes simplex virus NV1020 as a novel and promising therapy for hepatic malignancy
BACKGROUND: Patients with hepatic malignancy have a dismal prognosis with standard therapies. NV1020 is an oncolytic herpes simplex virus that has potential to be a safe and effective therapeutic agent for this disease. OBJECTIVE: We set out to discuss the development of NV1020 as an oncolytic agent...
Gorde:
| Egile Nagusiak: | , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2008
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3263932/ https://ncbi.nlm.nih.gov/pubmed/18549346 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/13543784.17.7.1105 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|